More specifically, African‐American populations, in whom low‐renin, volume‐expansive hypertension is a common comorbid cardiovascular condition (Cook, 1988), the use of augmenters of ACE‐inhibitor action is encouraged to reduce the very high doses of ACE inhibitors otherwise required. Here, ACE is linked to Hypertension.